Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Indium In-111 Product Approval Information - New Drug Application 2/19/02 (Supp 003)

Product name: Indium In-111 Chloride Solution
Manufacturer: Mallinckrodt, Inc, St. Louis, MO
Indication for Use: Use in radiolabeling Ibritumomab Tiuxetan (Zevalin) and remove use in radiolabeling Imciromab Pentetate (Myoscint)
Approval Date: 2/19/2002
Type of submission: New Drug Application Supplement


Approval Letter (PDF)

Label - (PDF)

Page Last Updated: 09/30/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English